Bluesky Facebook Reddit Email

Proteasome inhibition affects epigenetic mechanisms

Chronic ethanol feeding inhibits nuclear proteasome activity, altering epigenetic mechanisms and gene expression. Proteasome inhibition also affects the remethylation pathway, leading to decreased histone acetylation and increased betainehomocysteine methyltransferase (BHMT) enzyme.

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Scripps Florida scientists awarded $1.5M to fight major water and food parasites

Researchers at Scripps Florida have received a $1.5 million grant to develop novel drug targets for amebiasis and giardiasis, two serious water- and food-borne illnesses caused by microscopic parasites. The goal is to create small molecule inhibitors that target specific proteases playing a critical role in parasite lifecycle.

Compound has potential for new class of AIDS drugs

A new compound has been developed that targets the flap recognition pocket of the HIV-1 protease, inhibiting its activity. This mechanism is distinct from current protease inhibitors and holds promise for a new class of AIDS drugs with better drug-like properties.

Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

Early life family structure and microbially induced cancer risk and more

A 28-year study of Japanese-American men found that growing up in a large family or being born later in the family increased the risk of developing gastric adenocarcinoma. The results suggest that early-life social environment plays a significant role in microbially induced malignancies expressed decades later.

Drug combo may reduce protease inhibitor-related hardening of the arteries

A combination of a nucleoside reverse transcriptase inhibitor and a protease inhibitor may prevent the negative cardiovascular effects of long-term protease inhibitor use, including hardening of the arteries. This could allow patients to take their medications without worrying about these side effects.

Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

Study shows promise for simplified treatment of HIV infection

A preliminary study suggests that using a single boosted protease inhibitor instead of the standard regimen may be an effective treatment for select patients with HIV infection. The study found that 91% of participants experienced virologic success after 24 weeks of simplified therapy.

Enzyme inhibitors block replication of SARS virus

Researchers at Scripps Research Institute have identified a new class of potent SARS virus protease inhibitors, offering hope for developing a possible drug treatment against the disease. These benzotriazole esters block the enzyme and are stable enough to be used in clinical trials.

Computer simulation hints at new HIV drug target

Researchers at HHMI used molecular dynamics simulations to identify a potential new drug target for treating HIV, which is often resistant to existing medications. The study focused on a rare strain of HIV with mutations that can evade commonly prescribed drugs.

Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

Ethnic differences in response to HIV medicines

A study of 626 patients found that Black patients on HAART had a lower risk of atheroma than White and Hispanic patients. Genetic variants were associated with dyslipidemia in Hispanic patients, but not in others.

Protease inhibitors reach beyond HIV

Researchers found that HIV protease inhibitors (PIs) can inhibit programmed cell death in mouse models with hepatitis, shock, and stroke. PIs maintain mitochondrial integrity to prevent apoptosis, suggesting potential uses for related compounds in non-HIV disorders.

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

HIV-1 protease inhibitors: Effective against malaria?

Researchers found that HIV-1 protease inhibitors, such as saquinavir and ritonavir, effectively inhibit P. falciparum growth and demonstrate anti-malarial activity. The study builds on previous findings of antiretroviral agents reducing parasite adhesion to endothelial surfaces.

Pushing the envelope to overcome HIV drug resistance

Researchers explored strategies to combat HIV-1 protease resistance, a key factor in treatment failure. The study identified novel approaches to inhibit the enzyme, offering potential solutions to overcome drug resistance and improve treatment outcomes.

Environmental toxins can cause a model of Parkinson's disease in rats

Researchers have found that proteasome inhibitors can cause a model of Parkinson's disease in rats, mirroring symptoms such as slowness of movement and tremors. The study suggests that environmental factors, including exposure to toxins, may contribute to the development of Parkinson's.

GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

HAART and heart disease

Researchers found that HIV protease inhibitors directly promote atherosclerosis in mice by inducing changes in macrophages. A commentary article proposes a mechanism and suggests ways to disrupt this process. The study has significant implications for the long-term use of these drugs in managing chronic HIV infection.

New protease inhibitor held HIV at undetectable levels for four years

A phase II study of 100 patients with previously untreated HIV found that kaletra held the virus at undetectable levels for four years, with 72% maintaining suppressed viral loads. The results suggest that Kaletra remains a crucial option for initial therapy, helping to prolong time to resistance development.

Kestrel 3000 Pocket Weather Meter

Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.

Abacavir could play important future role in treatment of children with HIV-1

A new study published in The Lancet suggests that abacavir-containing regimens are more effective than zidovudine/lamivudine in children with HIV-1 who have not previously been treated. This finding could provide a good NRTI backbone for use with protease inhibitors and non-nucleoside reverse-transcriptase inhibitors.

A new strategy for treating psoriasis

Researchers develop innovative approach to treating psoriasis using a novel combination of therapies and biomarkers, offering new hope for patients suffering from the chronic skin condition.

Researchers uncover how some AIDS drugs may cause cardiovascular problems

Researchers have found that protease inhibitors used in AIDS treatment can lead to severe cardiovascular problems by accumulating a certain apolipoprotein in liver cells. This accumulation causes the liver cell to release excessive lipoprotein particles into the bloodstream, increasing the risk of heart disease.

Georgetown research uncovers new mechanism for suppressing HIV

Peptide-T, a synthetic compound, prevents HIV from entering healthy human cells by adhering to specific cellular receptors. This new mechanism of action offers an alternative to existing protease inhibitors, which can develop resistance and cause harmful side effects.

AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Researchers design new way to squelch errant enzymes

Scientists have developed a novel approach to inhibit protein kinase enzymes, which play a crucial role in triggering cancers, hardening of the arteries, and autoimmune diseases. The researchers' bisubstrate analogs effectively prevent these enzymes from working, offering a promising therapeutic strategy for various diseases.

Protease inhibitors linked to bone disease in HIV/AIDS patients

A new UC Francisco study reveals a link between chronic use of protease inhibitors and the development of avascular necrosis (AVN) of the femoral head in HIV/AIDS patients. Early diagnosis can lead to effective treatment, but high-risk hip replacement surgery is associated with infection risk for these patients.

Link found between AIDS medications and diabetes

Researchers link HIV-protease inhibitors to increased diabetes risk due to impaired glucose storage, prompting reevaluation of screening methods and development of new treatments. Up to 83% of patients on the drugs develop excess belly fat and type 2 diabetes.

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.

Bone deterioration linked to potent AIDS drugs

A study published in AIDS found an association between osteopenia and protease inhibitors, a class of medications used to treat HIV/AIDS. Researchers discovered that patients taking these medications were more likely to develop low bone-mineral density, which can lead to fractures.

Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

Researchers Document Transmission Of Protease-Resistant HIV

A team of researchers documented a case of transmission of protease-resistant HIV, which is resistant to six of the 11 approved HIV anti-retroviral drugs. The patient was infected through unprotected anal intercourse with a partner who had previously been treated with these drugs, highlighting the need for continued prevention efforts.

Answers To Access, Adherence And Tolerance Of Protease Inhibitors

Studies reveal that patients are more likely to discontinue protease inhibitors due to side effects and complexity of dosing regimen. Additionally, certain groups such as women, minorities, and those with less education are underrepresented in receiving potent drug cocktails containing protease inhibitors.

DJI Air 3 (RC-N2)

DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.

Extensive Phase II Data Of Amprenavir (141W94/VX-478) To Be Presented

Phase II data reveals amprenavir's potent drug profile, with sustained antiviral effects seen in patients treated with two-drug combinations. The medication is currently being evaluated in pivotal Phase III clinical trials and has an expected US new drug application filing later in 1998.

Researchers Finding May Boost Effectiveness Of Anti-HIV Drugs

Vanderbilt University Medical Center researchers found that a 'transporter molecule' called P-glyco protein may prevent protease inhibitors from reaching the virus, raising hope for boosting treatment effectiveness and reducing costs. The discovery could provide new strategies for treating HIV by targeting the protein's action.